Pain Relief Techniques for Rib Fractures

ES
GK
Overseen ByGeorge Koenig, DO
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: Thomas Jefferson University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests different methods to manage pain from rib fractures. Participants will join one of three groups: one using an ESP block (a type of nerve block) with ropivacaine, another using lidocaine infusions, and the last receiving standard pain treatment with various painkillers, including opioids. The researchers aim to determine which method most effectively reduces pain and opioid use in the first few days, as well as its impact on breathing and long-term pain. Individuals aged 55 and older with three or more broken ribs on one side who are hospitalized might be suitable for this trial. As a Phase 4 trial, this study involves treatments already FDA-approved and proven effective, aiming to understand how they can benefit more patients.

Will I have to stop taking my current medications?

The trial information does not specify if you need to stop your current medications. It's best to discuss this with the trial coordinators or your doctor.

What is the safety track record for these treatments?

Previous studies have shown promising safety results when using the Erector Spinae Plane (ESP) block with a catheter and ropivacaine. Research indicates that this method effectively manages pain from rib fractures, reducing pain and improving breathing without serious side effects. For instance, patients have reported better breathing and less pain without experiencing issues like low blood pressure.

Lidocaine, administered as an infusion, is also well-tolerated in controlled amounts. The FDA has approved it for various uses, suggesting it is generally safe. While side effects can occur, they are usually mild and manageable.

Overall, both treatments in the trial have demonstrated good safety records based on past research and FDA approvals, indicating they are generally safe for use in humans with minimal risk of severe side effects.12345

Why are researchers enthusiastic about this study's treatments?

Researchers are excited about these treatments because they offer new ways to manage pain from rib fractures. The ESP block with catheter using ropivacaine is unique because it provides continuous pain relief directly at the site of injury, potentially reducing the need for opioids, which can have significant side effects. On the other hand, the use of lidocaine as a bolus and infusion offers a systemic pain relief alternative with a different mechanism, acting as an anesthetic by blocking nerve signals throughout the body. These treatments aim to enhance pain management while minimizing reliance on standard care options like opioids and multimodal analgesia.

What evidence suggests that this trial's treatments could be effective for rib fractures?

In this trial, participants will receive one of the following treatments for rib fracture pain: the erector spinae plane (ESP) block with ropivacaine or lidocaine infusions. Research has shown that the ESP block with ropivacaine effectively reduces pain from broken ribs, lowering pain levels by about 21% and aiding in breathing without affecting blood pressure. It also reduces the need for opioids, offering a significant advantage. Meanwhile, lidocaine infusions provide quick pain relief and are often used for their numbing effect. Both treatments in this trial aim to manage pain effectively after rib injuries.46789

Who Is on the Research Team?

ES

Eric Schwenk, MD

Principal Investigator

Thomas Jefferson University

Are You a Good Fit for This Trial?

This trial is for adults over 55 with at least three rib fractures on one side, admitted to the hospital. They can't join if they're allergic to certain anesthetics, pregnant, have bilateral rib fractures, blood clotting issues, heart conduction problems, weigh under 40 kg or have other severe injuries or infections that could interfere.

Inclusion Criteria

I am 55 years old or older.
I have three or more broken ribs on one side and am hospitalized.

Exclusion Criteria

Pregnancy
I am allergic to certain local anesthetics or study drugs.
Coagulopathy (INR > 1.5; platelets < 100,000)
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 week
1 visit (in-person)

Treatment

Participants are randomly assigned to one of three analgesic techniques for rib fractures: ESP block with ropivacaine, lidocaine bolus and infusion, or standard care with multimodal analgesia and opioids

72 hours
Continuous monitoring during hospital stay

Follow-up

Participants are monitored for safety and effectiveness, including opioid use and pain ratings, and the development of chronic pain and post-discharge opioid use

90 days
Regular follow-up visits and assessments

What Are the Treatments Tested in This Trial?

Interventions

  • ESP block with catheter using ropivacaine
  • Lidocaine
Trial Overview The study compares three pain management methods for rib fractures: ESP block with ropivacaine infusion; lidocaine bolus and infusion; versus standard care including opioids. It aims to assess opioid use, pain levels, lung function improvements and potential reduction in chronic pain or long-term opioid need.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: ESP block with catheter using ropivacaine (bolus followed by continuous infusion)Experimental Treatment1 Intervention
Group II: Lidocaine bolus (1 mg/kg) and infusion starting at 1 mg/kg/hActive Control1 Intervention
Group III: Standard care with multimodal analgesia and opioidsActive Control1 Intervention

ESP block with catheter using ropivacaine is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Erector Spinae Plane Block for:
🇪🇺
Approved in European Union as Erector Spinae Plane Block for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Thomas Jefferson University

Lead Sponsor

Trials
475
Recruited
189,000+

Published Research Related to This Trial

The ultrasound-guided erector spinae plane block (ESP) is an effective and simple method for managing pain in patients with rib fractures, which can help prevent complications like atelectasis and pneumonia.
In a case study, the ESP block successfully managed pain in a patient with multiple rib fractures in the ICU, demonstrating its potential for improving patient outcomes in critical care settings.
Pain Management for Traumatic Rib Fractures with ESP Block in ICU.Gursoy, C., Kuscu, Y., Demirbilek, SG.[2021]
In a case series of 10 patients undergoing bilateral erector spinae plane (ESP) block for lumbar spine surgery, lidocaine showed a rapid absorption with peak concentrations (Cmax) ranging from 1.2 to 3.8 mg/L, which remained below toxicity limits.
The pharmacokinetics of lidocaine after ESP block indicated high bioavailability (average AUC0-3 of 76%) and a slightly prolonged elimination half-life in older patients, suggesting that age may influence drug metabolism.
Pharmacokinetics of lidocaine after bilateral ESP block.De Cassai, A., Bonanno, C., Padrini, R., et al.[2021]
The erector spinae plane (ESP) block is an effective alternative for pain relief in patients with acute rib fractures, which is important for preventing pulmonary complications.
This case report introduces the use of unilateral bilevel ESP catheters for a patient with flail chest, suggesting a novel approach to enhance analgesia in severe rib injuries.
Unilateral Bilevel Erector Spinae Plane Catheters for Flail Chest: A Case Report.Liu, R., Clark, L., Bautista, A.[2021]

Citations

Erector Spinae Plane Block as an Analgesic Intervention in ...Six studies reported pain scores 24 to 48 hours post block, maintaining an average reduction of 21% from pre block baseline, while a further ...
2.associationofanaesthetists-publications.onlinelibrary.wiley.comassociationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1111/anae.14579
The effect of erector spinae plane block on respiratory and ...Erector spinae plane blocks were associated with improved inspiratory capacity and analgesic outcomes following rib fracture, without haemodynamic instability.
Continuous erector spinae plane block for analgesia and ...Conclusion. Continuous ESP block provide adequate analgesia with better respiratory functions in patients with multiple rib fractures.
Continuous Erector Spinae Plane Blocks for Rib FracturesThe erector spinae plane block (ESPB) is a nerve block that covers multiple rib fractures with a single injection. This block entails injecting local anesthetic ...
Erector spinae plane block (ESPB) enhances hemodynamic ...ESPB was shown to enhance intraoperative hemodynamic stability, reduce opioid consumption and decrease postoperative analgesic consumption in patients who ...
Erector Spinae Plane block with fascial plane catheter for the ...Adults with rib fractures were randomised in a 1:1 ratio to either (i) ESP blockade and catheter, or (ii) placebo ESP blockade and catheter, ...
Continuous regional anesthesia with erector spinae plane ...ESP catheter placement and continuous regional anesthesia by EP is a safe, reasonable adjunct to treat pain from rib fractures.
183 A case report of erector spinae plane block ...Conclusions The ESP block both reduced the patients pain symptoms and improved his respiratory function. The patient much preferred the ESP block to the PCA he ...
Study Details | NCT03540095 | Erector Spinae Plane (ESP ...The primary outcome will be total opioid consumption in the first 3 days of nerve block. Secondary outcomes include highest visual analog pain score (VAS) with ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security